A glutamine metabolish-associated prognostic model to predict prognosis and therapeutic responses of hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) ranks among the most lethal malignancies around the world. However, the current management strategies for predicting prognosis in HCC patients remain unreliable. Our study developed a robust prognostic model based on glutamine metabolism associated-genes (GMAG...
Saved in:
| Main Authors: | Hao Xu, Hui Pan, Lian Fang, Cangyuan Zhang, Chen Xiong, Weiti Cai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Biology Direct |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13062-024-00567-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
by: Ding Nan, et al.
Published: (2025-01-01) -
Metabolism and spatial transcription resolved heterogeneity of glutamine metabolism in cervical carcinoma
by: Qian Liu, et al.
Published: (2024-12-01) -
Identification of alternative lengthening of telomeres-related genes prognosis model in hepatocellular carcinoma
by: FanLin Zeng, et al.
Published: (2024-11-01) -
CGRRF1 as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
by: Yao Rong, et al.
Published: (2025-01-01) -
High expression of MRPL52 can be used as a prognostic marker of hepatocellular carcinoma and is related to immune infiltration
by: Nan HUANG, et al.
Published: (2021-12-01)